Capinha Francisco, Ferreira Carlos Noronha
Serviço de Gastrenterologia e Hepatologia, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Clínica Universitária de Gastrenterologia, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisbon, Portugal.
GE Port J Gastroenterol. 2023 Oct 18;31(2):77-88. doi: 10.1159/000533161. eCollection 2024 Apr.
Nonmalignant portal vein thrombosis (PVT) is a common complication of cirrhosis especially at the stage of decompensations. The diagnosis of PVT in cirrhosis is often incidental and it may be detected during routine semestral abdominal ultrasound with Doppler during screening for hepatocellular carcinoma or during hospitalization for decompensated cirrhosis. After detection of PVT on abdominal ultrasound, it is important to evaluate patients with cross-sectional imaging to determine the age of thrombus, whether acute or chronic, the extent and degree of luminal occlusion of the portal vein, and to rule out hepatocellular carcinoma or other underlying malignancy. Factors influencing management include the degree and extent of luminal occlusion of PVT, potential listing for liver transplantation, and portal hypertension (PHT) complications such as variceal hemorrhage and refractory ascites, severity of thrombocytopenia, and other comorbidities including chronic kidney disease. Anticoagulation is the most common therapeutic option and it is specially indicated in patients who are candidates for liver transplantation. Interventional procedures including transjugular intrahepatic portosystemic shunt (TIPS) placement and mechanical thrombectomy may be used on a case-by-case basis in patients with contraindications or adverse events related to anticoagulation, who develop worsening PVT while on anticoagulant therapy, or have chronic PVT and PHT complications that are not manageable medically or endoscopically.
非恶性门静脉血栓形成(PVT)是肝硬化常见的并发症,尤其是在失代偿期。肝硬化患者的PVT诊断往往是偶然的,可能在肝细胞癌筛查的常规半年期腹部超声多普勒检查期间,或在失代偿期肝硬化住院期间被发现。腹部超声检测到PVT后,对患者进行横断面成像评估很重要,以确定血栓的年龄,是急性还是慢性,门静脉管腔阻塞的范围和程度,并排除肝细胞癌或其他潜在恶性肿瘤。影响治疗的因素包括PVT管腔阻塞的程度和范围、肝移植的潜在登记情况、门静脉高压(PHT)并发症如静脉曲张出血和难治性腹水、血小板减少的严重程度以及其他合并症,包括慢性肾脏病。抗凝是最常见的治疗选择,特别适用于肝移植候选患者。对于有抗凝禁忌证或相关不良事件、在抗凝治疗期间PVT恶化、或有慢性PVT和PHT并发症且药物或内镜治疗无法控制的患者,可根据具体情况采用包括经颈静脉肝内门体分流术(TIPS)置入和机械取栓术在内的介入治疗。